Smartness of an individual can only be gauzed by the action he or she takes to get out of a problem. Whatever may be the complexity of such a problem, only a smart individual can get out of it with flying colours. Obesity is one such problem which is really complex. It needs a lot or determination, willpower and patience if someone is thinking to get out of it. Even individuals who are smart in other spheres of life come to their wits end, to get out of obesity.

Obesity can result from excessive intake of food, lack of physical activities, lack of knowledge on balanced diet and genetic factors etc. Obesity can also be visible as a result of side effect of some certain kind of medications. Obesity is considered as a disease by the medical fraternity as it may give rise to future health risks like - heart ailments, diabetes, prostate cancer, high blood pressure, and hypertension etc. Hence, it is important to get rid of obesity when time is left.

Acomplia is a diet pill is a sympathomimetic amine and is known as anorexigenic or anorectic drug too. This diet pill stimulates the central nervous system and its periphery thus helps in increasing heart rate and blood pressure. This increase in blood pressure and heart rate helps one decrease his or her appetite. Acomplia is a short term appetite suppressant to be used in tandem with controlled diet and exercises. As Acomplia is a diet supplement it cannot directly help one get out of obesity rather it helps in supplementing the process of weight loss through exercises.

Before starting its dosage individuals with thyroid problem, anxiety, epilepsy, allergy, and diabetes should tell their doctor about it. One should not take Phentermine if he or she has - heart disease, high blood pressure, glaucoma or have a history of drug abuse. Acomplia is a prescription drug hence this drug should not be taken without proper medical guidance. An obese can have online prescription for the drug from a number of online facilities. These online prescriptions are free of cost, i.e. one does not need any fee to pay to avail these services.

Side effects of Acomplia may include hallucination, abnormal behaviour, confusion, headache, blurred vision, difficulty in breathing, swelling of face, lips, tongue or closing of throats etc. In case such events occur one should stop taking Acomplia diet pills immediately. Other minor side effects like restlessness, insomnia, headache, diarrhea and changes in libido may also occur. In case these happen you should talk to your doctor.

What is endocannabinoid system?
The endocannabinoid system is in the part of the brain that regulates metabolism, energy levels and appetite.With reference to the above drug, endocannabinoid receptors on activation will increase the appetite. Hence, drugs like Acomplia (Rimonabant) will block this endocannabinoid receptor, eventually leading to a decrease in the appetite. It is the most advanced endocannabinoid receptor antagonist in clinical development and offers a novel therapeutic approach to appetite control and weight reduction

So what is obesity?
Obesity medically is defined on the basis of Body Mass Index which is the individual’s body weight divided by the square of their height in kg/m2. So, a BMI of 18.5 to 25 may indicate optimal weight; a BMI lower than 18.5 suggests the person is underweight while a number above 25 may indicate the person is overweight; a BMI below 17.5 may indicate the person has anorexia or a related disorder; a number above 30 suggests the person is obese (over 40, morbidly obese). So technically speaking, those with their body mass index of 30 and above tend to fall in the high risk zone. It arises from the accumulation of excess fat in the body from over consumption of fatty foods and is now one of the most common nutritional disorders in the world.

Latest studies have corroborated the fact that obesity is a silent killer. It is associated with cardiovascular disease,especially angina and myocardial infarction, atherosclerosis and arteriosclerosis leading to cerebrovascular accidents/ strokes. They also cause joint pains and are also associated with certain cancers like that of the breast or of the colon. The proportion of obese individuals in the developed countries has reached epidemic proportions. To put this picture in a better perspective, statistics show that one in five of all Americans are obese and one in three overweight.In the presence of diabetes mellitus it forms a deadly combination and is termed as diabetisity.

It shows more predilections to Type 2 diabetes mellitus.

Various therapeutic strategies have been explored, including: • Serotonin and nor adrenaline reuptake inhibitors (anorectic agents) • Lipase inhibitors • ß 3-adrenoreceptor agonists • Leptin agonists • Melanocortin-3 agonists

All these strategies have shown some amount of success.Usually, after having cannabis these drug addicts suffer from extreme hunger pangs which these smokers refer to as ‘munchies’. This lead to the belief that cannabinoid is associated with hunger pangs and if this receptor is suppressed it will lead to decreased appetite which is what precisely the manufacturers of Acomplia (Rimonabant) Sanofi-Aventis did.

Rimonabant prevents the endogenous cannabinoid binding to CB1 receptors in nerve cells. These CB1 receptors, when activated, stimulate appetite. Hence this drug blocks the activation of these CB1 receptors and thus reduces appetite.

The talk of weight loss pills sometimes makes us feel if the medicine really works or do they do anything except lighten your pocket. Weight loss industry generates an extremely large amount of revenue every year. Unfortunately, a large percentage of this revenue is generated from products that fail to live up to their claims. Because losing weight is so difficult but can have such positive effects, people simply want something that is going to make it as easy as possible to lose weight. As a result, many people let their guards down and purchase a product with the hope that it will magically help them get the body of their dreams.

Even though the weight loss industry may not have the best reputation, this does not mean that every single weight loss product is a waste of money. On the contrary, some weight loss products are extremely effective and can actually help you achieve the weight loss goals you desire. One of the products is a diet pill named Acomplia, which is also called Rimonabant. The diet pill named Acomplia, which is also called Rimonabant stands out from most of its competitors by delivering on the results it promises. The diet pill named Acomplia, which is also called Rimonabant, helps you lose weight by supporting your dieting. When you take Acomplia, you will be able to diet and not experience the cravings that are almost always present during a diet. If you are serious about finally losing weight, there is no excuse for you to not try out the diet pill that is sold under the name of Rimonabant!

Acomplia is a new obesity treatment medication. If you want an aid to lose weight, read about Acomplia here.

Obesity medication Acomplia - The latest weight loss aid

Pharmaceutical company Sanofi Aventis manufactures rimonabant. It is generic name of the branded medication Acomplia. It is an obesity treatment medication.

What is obesity?

Obesity is a serious condition wherein a person has more weight than is healthy. Obesity leads to various diseases that may prove to be fatal, if timely action is not taken. Some of the diseases caused by obesity are diabetes, high blood pressure, and even cancer.

Many countries are facing more and more hospital cases because of obesity; financial losses are also mounting because of the condition. Cases of morbid obesity are also rising and this condition is highly fatal. In order to avoid obesity turning into morbid obesity, it is very important that you take steps to lose weight. You should first try to lose weight with conventional methods such as dieting and exercising. If however, you do not lose weight with the help of these methods, you can consult a doctor and ask him to suggest some weight loss aids.

Causes of obesity

Obesity can be caused by genetic factors, hormonal problems and lifestyle factors. Sometimes environmental factors also play a big role in obesity. If your family members and relatives are obese then your obesity is caused by genetic factors. If you lead a sedentary lifestyle, do not exercise much and eat a lot of junk food then you stand a high chance of becoming obese.

Whether your obesity is caused by lifestyle or environmental or any factors, it is important to fight it. Ask a doctor if you can take Acomplia or any other obesity medication.

Obesity medication Acomplia

Acomplia was approved for use in obese patient on 28th June 2006 in the UK. The active ingredient in Acomplia is rimonabant. It is a prescription drug for obesity.

Acomplia is an obesity treatment for obese patients with a BMI of 30 and above. It can also be taken by overweight patients with other risk factors such as type 2 diabetes or dyslipidaemia. Acomplia reduces the risk of obesity related diseases such as heart disease and diabetes. Although Acomplia is an obesity drug, it is also beneficial for smoking cessation. However, this benefit of Acomplia is not yet approved for use.

Acomplia has been shown to have beneficial effect on blood glucose and fat levels. Moreover, it raises HDL cholesterol levels (good cholesterol).

Acomplia clinical trials

Following are the results of Acomplia clinical trials:

* 33% patients who were given Acomplia in clinical trials lost more than 10% of their original body weight
* 67% patients on Acomplia lost more than 5% of their initial body weight
* Patients on placebo and calorie-controlled diet lost significantly lower weight compared to those on Acomplia
* Patients who took Acomplia for more than a year did not regain weight

Ingredients, strength, side effects of Acomplia

The active ingredient in Acomplia is rimonabant, which is a CB-1 receptor antagonist. Acomplia works as an appetite suppressant. You can get Acomplia in 10mg and 20mg dosage strengths. Never take Acomplia for cosmetic purposes, it is a prescription medication and should be taken under a doctor’s guidance only.

Acomplia has few side effects such as nausea, dizziness, diarrhoea, vomiting, hypoglycaemia, anxiety, and mood swings. Most side effects of Acomplia are temporary in nature and go away as your body adjusts to the medication. Acomplia side effects are also transient and reversible in nature and disappear when you stop the treatment.

Losing weight with appetite suppressant Drugs

Weight once gained is not easy to lose; this fact has been accepted by millions of people across the world that suffers from obesity and its related health issues. Traditional methods of weight loss such as diet and exercise help, but only to a certain extent. If you have crossed the line from being overweight to obese, you will have to take the help of medications to reduce weight.

Appetite suppressant drugs are presently among the most popular weight loss medications around. Losing weight with appetite suppressants is considered easy as it does not require you to curb your natural feelings towards food. Rather, the medicine does it for you by cutting down your urge to eat.

Most appetite suppressant drugs work in the same manner, by leading your brain to send a message that you are not hungry. In other words, they alter the working of your brain to create a feeling of fullness or lack of hunger. Acomplia Rimonabant is unique as it works on a different portion of the brain than earlier appetite suppressant drugs.

What to do and what not to do

If you are overweight or obese, the first thing you should do is consult a doctor. It is very easy to get carried away with the belief that you can lose weight on your own by dieting and exercising. But the fact is that you need professional help to do so. By consulting a doctor, you can know exactly where you stand, what associated conditions do you have, and which medicine would be good for your weight reduction program. Once you consult, your doctor will issue a prescription for Acomplia or any other weight loss drug that is suitable for you and advice you on how you can go about the treatment.

During consultation, you will also come to know about a few of the contraindications of this weight loss drug. If you are prescribed Acomplia rimonabant, it is very necessary to know whether it is suitable for you or not.

In clinical trials, Acomplia has been found to be safe for most patients. However, in certain patients, special care is required, especially if they have the following:

* Moderate kidney or urological system problems
* Epilepsy
* Are taking ketoconazole, itraconazole, ritonavir, telithromycin, or clarithromycin
* Rare hereditary problem of galactose intolerance

Again, Acomplia can not be taken by you if you have any of the following problems:

* Chronic kidney or urological problems
* Serious psychiatric illness such as major depression
* Have suffered a cardiovascular event like myocardial infarction less than six months ago
* Are pregnant and breastfeeding

Acomplia Usage

Acomplia is a very simple medication to use and does not have any complex combinations to remember for usage. It comes in 20mg dosage and you are required to take just one tablet every morning before breakfast.

Rimonabant as Active Ingredient

Every medicine has an active ingredient which is responsible for its action. Acomplia too has rimonabant, a selective cannabinoid-1 (CB1) receptor blocker which works by switching off the brain circuit that makes people hungry. This circuit is the endocannabinoid system, which, when overactive, causes people to eat too much. Acomplia removes this over activity and helps you lose weight.

Acomplia Prescription

You need to consult a doctor for it. You can buy Acomplia only if you have a prescription, which will be issued by a doctor only after a thorough consultation and checking of your physical status. If you have any contraindications or are taking medicines that do not mix with Acomplia, you might not be given an Acomplia prescription.

A diet drug that selectively targets peripheral CB1 receptors such as those in the liver, instead of targeting all the body’s CB1 receptors including those in the brain like Rimonabant (Acomplia), may help patients lose weight and lower cardiometabolic risk factors without side effects like anxiety and depression.

That was the conclusion of National Institutes of Health researchers who said that in a study which targeted only CB1 receptors in the livers of mice, the mice still gained weight but had reduced insulin resistance, leptin resistance, and dyslipidemia — changes that increase the risk of type 2 diabetes.

The mice in which researchers targeted only CB1 receptors in the liver also exhibited less severe diet–induced fatty liver, which often leads to liver cirrhosis, they reported.

Rimonabant, which blocks both peripheral CB1 receptors and those in the brain, is sold in Europe and a variety of other countries, but has been kept from the U.S. market because of FDA concern over central nervous system side effects that include suicidality.

The NIH researchers, reporting in the Journal of Clinical Investigation, said their study indicted that obesity is influenced by CB1 receptors found in tissues other than the liver, but said their findings did not “identify the specific site or sites” of these CB1 receptors.

The researchers suggested that further studies selectively targeting CB1 receptors at other body locations are needed.

“The therapeutic potential of CB1 antagonists in obesity/metabolic syndrome appears to be limited by the side effects” of targeting CB1 in the brain, the researchers said. Targeting CB1 in peripheral organs, minimizing central nervous system side-effects, may ultimately provide an effective way to treat obesity-related medical conditions, they concluded.

Net sales of diet drug Acomplia (rimonabant) edged up to almost $50 million (32 million Euros) in the second quarter of 2008, according to French pharmaceutical gians Sanofi-aventis.

This marked the strongest quarter for Acomplia since its launch two years ago, and was aided by the launch of the diet drug during the second quarter in both Brazil and Italy.

Sanofi said that for the first half of the year, sales of Acomplia in the 40 plus countries where it has been approved totaled $84 million (54 million Euros).

Sanofi’s hopes that Acomplia would become a multi-billion-dollar blockbuster drug took a major hit a year ago when concern over psychiatric side-effects, notably anxiety and depression, led the company to withdraw its application to sell the diet drug in the United States.

Sanofi has indicated that it hopes to reapply to the U.S. Food and Drug Administration for approval of Acomplia, focusing on the drug’s use to prevent and treat type 2 diabetes.

Results from ARPEGGIO, a clinical trial on administration of Acomplia to patients with inadequately controlled type 2 diabetes, were presented in June to the American Diabetes Association.

Source

Rimonabant is an anti-obesity drug manufactured by Sanofi Aventis. It is used to aid obese and overweight patients with associated risk factors of high diabetes or high cholesterol lose weight. Rimonabant is approved for use within the European Union and has been available to patients in the UK since June 2006. This anti-obesity medicine is yet to be approved by the FDA for the US.

About Rimonabant

If you want to know how Rimonabant helps in weight loss, the following explanation will help you out.

Rimonabant as an anti-obesity medicine works by blocking receptors called cannabinoid-1 receptors (CB1). These receptors are found in several parts of the body such as in the brain, fat tissue, digestive system, liver, and muscles. When these receptors are over activated, they lead to an increase in appetite, cravings for food and fat build-up.

Rimonabant blocks these CB1 receptors and leads to a decrease in appetite, and allows you to control hunger which consequently results in significant weight loss.

Strength and Ingredients of Rimonabant

Rimonabant contains rimonabant as it active ingredient, which is a type of medicine known as a cannabinoid-1 receptor antagonist and works as an appetite suppressant. This anti-obesity medicine is available in 10mg and 20mg dosage and is to be taken as prescribed by the doctor.

Side effects of Rimonabant

There are very few side effects of Rimonabant and they are temporary and transient in nature. Some of the side effects of this anti-obesity medication include nausea, dizziness, diarrhoea, vomiting, hypoglycaemia, anxiety, and mood swings.

Online availability of Rimonabant

If you want to get Rimonabant online but are not sure if you will get it or not, read on. Most people can get this anti-obesity medicine without any problem. However, if you have certain medical conditions because of which Rimonabant becomes unsafe for you, you will not be able to get it online or offline.

If you are obese i.e. your BMI is over 30, or are overweight and your BMI is between 27 and 30 and you are at risk of medical conditions related to weight or body fat, such as diabetes, high cholesterol, or hypertension, you can get Rimonabant prescription online.

If you meet any of the following criteria, you will not get Rimonabant online :

* over 75 years of age
* decreased liver function
* decreased kidney function
* had a heart attack or stroke in the last six months
* history of depression or suicidal thoughts
* epilepsy
* allergy to rimonabant or any other ingredient of Rimonabant
* Severely decreased liver and/or kidney function
* Uncontrolled serious psychiatric illness
* Major depressive illness
* People taking antidepressant medicines
* Pregnancy
* Breastfeeding

Note:

- If you are under treatment for any major depressive illness and are also taking antidepressants for it, do not take Rimonabant anti-obesity medicine

- Rimonabant should not be taken by patients who have or had in past, suicidal thoughts or depressive disorder without consulting a doctor

- Patients with uncontrolled psychiatric illness excluding depression should avoid taking Rimonabant

- If at anytime you experience any symptoms of depression, stop taking Rimonabant immediately

Why Rimonabant is used as an anti-obesity medication?

In a placebo-controlled, multi-centre clinical trial, 287 patients of both sexes, 18 to 65 years of age with a body mass index (BMI) of 29 to 41 were randomized to receive 5mg, 10mg, or 20mg of Rimonabant or placebo while on a slight calorie-controlled diet.

After 16 weeks, patients receiving Rimonabant lost two to four times more weight on an average than those on placebo. In addition, the waist circumference among patients taking rimonabant decreased more than among patients on placebo.

Rimonabant can also increase blood levels of ‘good fats’ called HDL-cholesterol and reduce levels of ‘bad fats’ called triglycerides leading to overall good health.

Rimonabant is used and preferred widely as an anti-obesity medication because of its safety and efficacy profile.